Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Marie Skłodowska-Curie Action · Running

SupDSB Mapping genetic suppression interaction networks in DNA break repair disorders

Coordinator
Institut Pasteur, France
Runs
1 September 2023 to 31 August 2025
Status
Running
EU funding
€212k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101066732

What the project is doing

In the project's own words, from its summary on CORDIS.

DNA double-strand breaks (DSBs) occur frequently during a cell’s lifetime and constitute the most cytotoxic DNA lesion. DSBs compromise genetic integrity and have the potential to trigger cell death and generate pathological mutations. To counteract such threat, cells possess a complex protein network termed DSB response (DSBR) which senses, signals and repairs DSBs. Two predominant mechanisms repair DSBs: homologous recombination (HR) and non-homologous end joining (NHEJ).

While loss of DSBR factors such as KU and XRCC4 (i.e. NHEJ proteins) or BRCA1 and BRCA2 (i.e. HR proteins) leads to early embryonic lethality and cell death, inactivating somatic mutations in these very same genes are associated with certain immunological and neurological disorders, premature ageing and cancer. This implies the existence of a suppressive (epi)genetic background that enables diseased cells to tolerate the otherwise lethal loss of essential DSBR factors.

This project aims to systematically identify suppressor mutations which rescue viability upon loss of essential HR (BRCA1 and BRCA2) and NHEJ (KU80 and XRCC4) effectors. To reach such goal, I propose to (a.) genetically sensitize wild-type “healthy” mouse embryonic stem cells and B lymphoid cells by introducing mutations using a genome-wide CRISPR KO library. In such diversely sensitized background, I will then (b.) trigger the acute degradation of KU80, XRCC4, BRCA1 and BRCA2 proteins, using the auxin-inducible degron (AID) system.

Suppressor mutations will be directly identified by sequencing sgRNA retrieved from survivor cells. (c.) The resulting suppression network maps will be integrated to clinical datasets to identify the relevance of these mutations in disease. Together, this project will unravel the DSBR protein networks that permit cell survival under different DNA repair-deficient conditions, encountered notably in cancer; paving way for personalized disease prevention and treatment strategies.

Topics

Who is involved

OrganisationCityCountryRole
Institut PasteurParisFranceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI